FIELD: medicine, particularly, experimental cardiology. SUBSTANCE: surplus pressure is created inside cavities of incubated heart to prevent development of ischemic contracture. Disclosed simulator of myocardial ischemia allows studying pathogenesis of disorder in cardiac muscle at ischemic contracture and relaxation of cardiomyocytes. EFFECT: promising simulator.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING THE STATE OF MYOCARDIUM IN CARDIOSURGICAL INTERVENTIONS UNDER CONDITIONS OF CARDIOPLEGIC PROTECTION | 2017 |
|
RU2651364C1 |
| METHOD FOR RECONDITIONING A DONOR HEART | 2021 |
|
RU2777097C1 |
| ANTIISCHEMICALLY-ACTIVE AGENT | 1988 |
|
RU2007985C1 |
| METHOD FOR ASSESSING MYOCARDIAL INJURY IN ISOLATED HEART PERFUSION BY LANGENDORFF METHOD | 2023 |
|
RU2814370C1 |
| METHOD OF PRESERVATION OF A DONOR HEART | 2020 |
|
RU2743235C1 |
| SURGICAL METHOD FOR TREATING CARDIAC ISCHEMIA DISEASE | 1998 |
|
RU2200042C2 |
| METHOD OF SURGICAL TREATMENT OF HEART DISEASES OF ISCHEMIC GENESIS | 2005 |
|
RU2361529C2 |
| METHOD OF PROPHYLAXIS AND TREATMENT OF PATIENT WITH MYOCARDIUM ISCHEMIA IN CORONARY-INVASIVE OPERATIONS | 1999 |
|
RU2146933C1 |
| METHOD OF MODELLING STRESSOR INJURIES OF MYOCARDIUM | 0 |
|
SU1272348A1 |
| METHOD FOR STIMULATING ACTO-, CARDIO- AND NEUROPROTECTION IN CONDITIONS OF FORCED PHYSICAL ACTIVITY IN EXPERIMENT BY USING ALLOGENIC BIOMATERIAL | 2024 |
|
RU2826978C1 |
